Phase I trial of the anti-idiotypic monoclonal antibody (mAb) ACA-125 in patients with epithelial ovarian, fallopian tube or primary peritoneal cancer
2004 ◽
Vol 22
(14_suppl)
◽
pp. 5018-5018
Keyword(s):
Phase I
◽
2019 ◽
2019 ◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 5018-5018
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 5078-5078
◽